Yale Depression Research Program
Principal Investigator
Mission
The Yale Depression Research Program is committed to advancing the treatment of unipolar depression by improving our ability to diagnose and treat mood disorders through a variety of research studies.
Who is eligible for research?
For most studies, men and women between 18 and 65 years of age who meet criteria for major depression and are free from recent drug and/or alcohol abuse are potentially eligible.
Evaluation Process
Potential subjects will be screened by phone to rule out any obvious exclusion criteria. Those who may be eligible for a study will be invited to our clinic for a comprehensive evaluation free of charge.
Contact Us
For more information about our clinic and current research studies, please call Jane Wanyiri at 203-764-9131.
Web Site
Current Studies
- Children's Health, Mental Health & Behavioral ResearchKetamine for severe adolescent depression: intermediate-term safety and efficacyPrincipal Investigator: Michael Bloch
- Addictive Behaviors, Mental Health & Behavioral Research, Obesity & Weight ControlCognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute TreatmentPrincipal Investigator: Carlos Grilo
- Child Development & Autism, Diseases of the Nervous System, Genetics - Adult, Genetics - Pediatric, Mental Health & Behavioral ResearchGenetic and molecular studies of developmental neuropsychiatric disordersPrincipal Investigator: Thomas Fernandez
- Diseases of the Nervous System, Mental Health & Behavioral ResearchExamination of Glutamate and mGluR5 in Psychiatric DisordersPrincipal Investigator: Irina Esterlis
- Mental Health & Behavioral ResearchStudy to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for SuicidePrincipal Investigator: Michael Bloch